We are live on ! Find out more
AACP

Advantage Alpha Capital Partners Portfolio holdings

AUM $332M
1-Year Est. Return 12.78%
This Fund
S&P 500
This Quarter Est. Return
-7.88%
1 Year Est. Return
+12.78%
3 Year Est. Return
+79.23%
5 Year Est. Return
+110.24%
10 Year Est. Return
–
AUM
$458M
AUM Growth
-$73.5M
Cap. Flow
-$33.1M
Cap. Flow %
-7.21%
Top 10 Hldgs %
19.44%
Holding
170
New
12
Increased
37
Reduced
105
Closed
16

Top Buys

Rank Stock Value
1
STVN icon
Stevanato
STVN
+$10.4M
2
CCC
CCC Intelligent Solutions
CCC
+$6.84M
3
TREX icon
Trex
TREX
+$4.97M
4
PCOR icon
Procore
PCOR
+$4.43M
5
WTS icon
Watts Water Technologies
WTS
+$4.28M

Top Sells

Rank Stock Value
1
GMS
GMS Inc
GMS
+$8.21M
2
FCFS icon
FirstCash
FCFS
+$8.01M
3
FAF icon
First American
FAF
+$6.89M
4
HRT
HireRight Holdings Corporation
HRT
+$6.81M
5
KEX icon
Kirby Corp
KEX
+$6.45M

Sector Composition

Rank Sector Weight
1 Industrials 28.53%
2 Technology 21.91%
3 Consumer Discretionary 12.07%
4 Healthcare 11.44%
5 Financials 6.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SLM icon
76
SLM Corp
SLM
$4.97B
$2.27M 0.5%
109,198
-60,164
-36% -$1.27M
MSM icon
77
MSC Industrial Direct
MSM
$6.66B
$2.13M 0.46%
26,794
-32,065
-54% -$2.85M
HLIO icon
78
Helios Technologies
HLIO
$2.41B
$2.04M 0.44%
42,636
-16,204
-28% -$776K
NGVT icon
79
Ingevity
NGVT
$2.39B
$1.95M 0.43%
44,653
-31,108
-41% -$1.5M
EYE icon
80
National Vision
EYE
$1.37B
$1.92M 0.42%
146,450
+23,390
+19% +$383K
OMCL icon
81
Omnicell
OMCL
$1.51B
$1.89M 0.41%
69,773
-38,181
-35% -$1.11M
ADMA icon
82
ADMA Biologics
ADMA
$2.09B
$1.72M 0.37%
153,551
-30,915
-17% -$259K
HALO icon
83
Halozyme
HALO
$12B
$1.28M 0.28%
24,506
-2,573
-10% -$113K
VCEL icon
84
Vericel Corp
VCEL
$2.1B
$1.04M 0.23%
22,611
-2,377
-10% -$112K
ORGO icon
85
Organogenesis Holdings
ORGO
$224M
$1M 0.22%
358,454
-37,662
-10% -$101K
VCYT icon
86
Veracyte
VCYT
$3.48B
$991K 0.22%
45,729
-4,805
-10% -$101K
DVAX
87
DELISTED
Dynavax Technologies
DVAX
$901K 0.2%
80,250
-8,433
-10% -$98.2K
MDXG icon
88
MiMedx Group
MDXG
$656M
$877K 0.19%
126,592
-13,301
-10% -$93.5K
VYGR icon
89
Voyager Therapeutics
VYGR
$218M
$875K 0.19%
110,681
-11,630
-10% -$97.5K
ALKS icon
90
Alkermes
ALKS
$7.95B
$851K 0.19%
35,298
-3,710
-10% -$91K
XNCR icon
91
Xencor
XNCR
$1.94B
$812K 0.18%
42,871
-4,504
-10% -$96.7K
IRWD icon
92
Ironwood Pharmaceuticals
IRWD
$682M
$773K 0.17%
118,514
-12,452
-10% -$88.1K
ARCT icon
93
Arcturus Therapeutics
ARCT
$432M
$658K 0.14%
27,040
-2,841
-10% -$86.2K
MNKD icon
94
MannKind Corp
MNKD
$1.27B
$652K 0.14%
+124,968
New +$567K
ACAD icon
95
Acadia Pharmaceuticals
ACAD
$5.02B
$619K 0.14%
+38,074
New +$614K
TGTX icon
96
TG Therapeutics
TGTX
$8.26B
$605K 0.13%
+34,030
New +$543K
KNSA icon
97
Kiniksa Pharmaceuticals
KNSA
$6.09B
$584K 0.13%
+31,258
New +$586K
CPRX
98
DELISTED
Catalyst Pharmaceutical
CPRX
$578K 0.13%
+37,320
New +$581K
WHD icon
99
Cactus
WHD
$4.86B
$512K 0.11%
9,699
-1,054
-10% -$53.7K
SBOW
100
DELISTED
SilverBow Resources, Inc.
SBOW
$477K 0.1%
12,598
-1,370
-10% -$48.1K
2 3
4
5 6

Similar funds

CPA
Court Place Advisors Ellicott City, Maryland $332M AUM 16.16% 1-Year Est. Return
PAWA
Palo Alto Wealth Advisors Palo Alto, California $343M AUM 33.47% 1-Year Est. Return
EE
EWG Elevate Roseville, California $320M AUM 18.11% 1-Year Est. Return
GB
Gunma Bank Gunma, Japan $319M AUM 1.17% 1-Year Est. Return
SC
Solari Capital Palm Beach Gardens, Florida $318M AUM
SFG
Sterling Financial Group Pasadena, California $316M AUM 10.54% 1-Year Est. Return
PA
Pineridge Advisors St. Charles, Missouri $350M AUM 6.38% 1-Year Est. Return
BCCM
Bridge Creek Capital Management West Barnstable, Massachusetts $360M AUM 16.27% 1-Year Est. Return

Advantage Alpha Capital Partners's Q2 2024 Portfolio in Review

As of Q2 2024, Advantage Alpha Capital Partners held 170 positions worth $458M, down 14% from $532M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Advantage Alpha Capital Partners withdrew a net $33.1M in Q2 2024, closing 16 positions and reducing 105 holdings. Its most notable exit was FirstCash, an estimated $8.01M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 29% of assets, down from 33% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Advantage Alpha Capital Partners opened a new position in Stevanato worth $8.2M.

  • Advantage Alpha Capital Partners's largest Q2 2024 buy was Stevanato: 446,967 shares worth $8.2M.
  • Advantage Alpha Capital Partners added most to Trex in Q2 2024, an estimated $4.97M increase.
  • Advantage Alpha Capital Partners's biggest Q2 2024 reduction was GMS Inc, cutting an estimated $8.21M.
  • Advantage Alpha Capital Partners fully exited FirstCash in Q2 2024, selling an estimated $8.01M.
  • Advantage Alpha Capital Partners's ten largest holdings make up 19% of its $458M portfolio in Q2 2024.
  • Advantage Alpha Capital Partners opened 12 new positions and closed 16 in Q2 2024.
  • Advantage Alpha Capital Partners's portfolio value fell 14% quarter-over-quarter to $458M.

Based on Advantage Alpha Capital Partners's 13F filing for Q2 2024, filed 13 Aug 2024.